期刊文献+

CD40基因多态性与冠状动脉不稳定粥样斑块的相关性

Association of CD40 gene polymorphism with unstable coronary atherosclerotic plaque
原文传递
导出
摘要 目的探讨CD40基因启动子区-1C/T单核苷酸多态性位点(SNP)与冠状动脉(冠脉)不稳定粥样斑块的相关性。方法 474例冠心病(CHD)患者冠脉造影(CAG)粥样斑块形态学分型为Ⅰ型(131例)、Ⅱ型(179例)和Ⅲ型(164例),采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术检测CD40基因多态性及测序鉴定;并与225例CAG正常者对照。结果 C等位基因频率CHD组明显高于对照组(52.6%vs.42.8%)(P<0.05),而T等位基因频率CHD组明显低于对照组(20.3%vs.32.0%)(P<0.05);CHDⅠ、Ⅱ、Ⅲ亚组C等位基因频率分别为43.1%、56.4%、56.1%,T等位基因频率分别为56.9%、43.6%、43.9%,Ⅱ型、Ⅲ型亚组C等位基因频率高于Ⅰ型亚组,而T等位基因频率低于Ⅰ型亚组(P<0.05)。结论 CD40-1C/TSNP位点与冠脉斑块的不稳定性相关,C等位基因增加了斑块的易损风险。 Objective To investigate whether CD40 gene (-1C/T) single nucleotide polymorphism(SNP) is associated with unstable coronary atherosclerotic plaque.Methods According to the morphological division of the plaque,474 patients with coronary angiography were divided into three groups of type Ⅰ lesion(131 cases),typeⅡ lesion (179 cases) and type Ⅲ lesion(164 cases).The results were compared to those with normal CAG(225 cases).The gene polymorphism was measured by the polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) and identified by sequencing.Results C allele frequency in patients with CHD was significantly higher than that in control group(52.6% vs. 42.8%)(P0.05),while T allele frequency was lower than that in control group(20.3% vs. 32.0%)(P0.05).Among the subgroups in patients with CHD,the frequencies of C allele were 43.1%,56.4% and 56.1%,and those of T allele were 56.9%,43.6% and 43.9%,respectively.C allele frequencies of typeⅡ and type Ⅲ lesion subgroups were higher than those of type I lesion subgroup(P0.05).Conclusion CD40-1C/T polymorphism is associated with unstable coronary atherosclerotic plaque.The C allele frequency increases the risk of rupture of vulnerable plaque.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第13期1507-1510,共4页 Jiangsu Medical Journal
基金 江苏省医学重点人才基金(RC2007033) 镇江市社会发展基金(SH2008030)
关键词 冠心病 单核苷酸多态性 CD40 Coronary heart disease Single nucleotide polymorphism CD40
  • 相关文献

参考文献2

二级参考文献16

  • 1Phipps RIR Atherosclerosis: the emerging role of inflammmation and the CD40-CD40 ligand system. Proc Natl Acad Sci USA 2000: 97: 6930-2.
  • 2Michelson AD. Barnard MR. Krueger LA. Frelinger AL 3rd.Furman MI. Evaluation of platelet function by flow cytometry. Methods 2000: 21: 259-70.
  • 3Kaski JC. Chester MR. Chen L. Katritsis D. Rapid anglographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis norphology .Circulation 1995: 92: 2058-65.
  • 4Kai H. lkeda H. Yasukawa H. Kai M. Seki Y. Kuwahara F. et al. Peripheral blood levels of matrix metalloproteases-2 and-9 are elevated in patients with acute coronary s vndronles. J Am Coil Cardiol 1998: 32: 368-72.
  • 5Inokubo Y.Hanada H. Ishizaka H. Fukushi T. Kamada T.Okumura K.Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 2001;141:211-7.
  • 6Yan JC. Wu ZG. Li L. Zhong RQ. Kong XT. The clinical implications of increased expression of CD40L in patients with acute coronary syndromes, Chin Med J 2002: 115:491-3.
  • 7Peng DQ. Zhao SP. Li YF. Li J, Zhou HN. Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome. Clin Chim Acta 2002: 319: 19-26.
  • 8Phipps RP. Koumas L. Leung E. Reddy SY. Blieden T.Kaufman J. The CD40-CD40 ligand system: a potential therapeutic target in atherosclerosis. Curt Opin lnvestig Drugs 2001: 2: 773-7.
  • 9Ozmen J. Bobryshev YV, Lord RS. CD40 co-stimulatory molecule expression by dendritic cells in primary atherosclerotic lesions in carotid arteries and in stenotic saphenous vein coronary artery grafts. Cardiovasc Surg 2001: 9: 329-33.
  • 10Math F. Schonbeck U. Sukhova GK. Atkinson E. Libby P.Reduction of atherosclerosis in mice by inhibition CD40 sinalling. Nature 1998: 394: 200-3.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部